Monitoring and reversal of neuromuscular block

American Journal of Health-System Pharmacy

Volumn 56, Issue 11 SUPPL. 1, 1999, Pages

  Bevan, David R ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Edrophonium; Neostigmine; Neuromuscular blockade; Parasympathomimetic agents; Pyridostigmine; Rapacuronium; Skeletal muscle relaxants; Toxicity

Indexed keywords

ATRACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; RAPACURONIUM BROMIDE; SUXAMETHONIUM; VECURONIUM;

ANESTHESIA MECHANISM; CONFERENCE PAPER; DOSE RESPONSE; DRUG MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE EXCITATION; NEUROMUSCULAR BLOCKING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0033152188     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.suppl_1.s10     Document Type: Conference Paper

References (24)

1. Griffith HR, Johnson GE. The use of curare in general anesthesia. Anesthesiology. 1942; 3:418-20.
2. Viby-Mogensen J, Jørgensen BC, Ørding H. Residual curarization in the recovery room. Anesthesiology. 1979; 50:539-41.
3. Lennmarken C, Lofstrom JB. Partial curarization in the postoperative period. Acta Anaesthesiol Scand. 1984; 28:260-2.
4. Beemer GH, Rosental P. Postoperative neuromuscular function. Anaesth Intensive Care. 1986; 14:41-5.
5. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology. 1988; 69:272-6.
6. Brull SJ, Silverman DG, Ehrenwerth J. Problems of recovery and residual neuromuscular blockade: pancuronium vs. vecuronium. Anesthesiology. 1988; 69:A473. Abstract.
7. Jensen E, Engbæk J, Anderson BN et al. The frequency of residual neuromuscular blockade following atracurium (A), vecuronium (V) and pancuronium (P): a multicenter randomized study. Anesthesiology. 1990; 73:A914. Abstract.
8. Donati F, Antzaka C, Bevan DR. Potency of pancuronium at the diaphragm and the adductor pollicis in humans. Anesthesiology. 1986; 65:1-5.
9. Chauvin M, Lebreault C, Duvaldestin P. The neuromuscular blocking effect of vecuronium on human diaphragm. Anesth Analg. 1987; 66:117-22.
10. Cantineau JP, Porte F, d'Honneur G et al. Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients. Anesthesiology. 1994; 81: 585-90.
11. Ali HH, Utting JE, Gray C. Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth. 1970; 42:967-78.
12. Ali HH, Wilson RS, Savarese JJ et al. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth. 1975; 47:570-4.
13. Drenck NE, Ueda N, Olsen NV et al. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology. 1989; 70:578-81.
14. Ansermino JM, Sanderson PM, Bevan JC et al. Acceleromyography improves detection of residual neuromuscular blockade in children. Can J Anaesth. 1996; 43:569-94.
15. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997; 86:765-71.
16. Eriksson LI, Lennmarken C, Wyon N et al. Attenuated ventilatory response to hypoxaemia after vecuronium-induced neuromuscular block. Acta Anaesthesiol Scand. 1992; 36:710-5.
17. Eriksson LI, Sundman E, Olsson R et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Anesthesiology. 1997; 87:1035-43.
18. Berg H, Viby-Mogensen J, Roed J et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiol Scand. 1997; 41:1095-103.
19. Baurain MJ, Hoton F, D'Hollander AA et al. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium? Br J Anaesth. 1996; 77:496-9.
20. Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after vecuronium. Anesth Analg. 1995; 80:1168-74.
21. Naguib M, Abdulatif M, al-Ghamdi A. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade. Anesthesiology. 1993; 79:739-45.
22. Kao YJ, Le ND. The reversal of profound mivacurium-induced neuromuscular blockade. Can J Anaesth. 1996; 43:1128-33.
23. Wierda JM, van den Broek L, Proost JH et al. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant: a comparison with succinylcholine. Anesth Analg. 1993; 77:579-84.
24. Bevan DR, Purdy FR, Donati F et al. "Rescue" reversal of ORG 9487 blockade. Anesth Analg. 1998; 86:5428.